CoChat

Cholesterol Lowering and Coronary Revascularization

Ohman, E. Magnus, Nanna, Michael G. · 2021 · Journal of the American College of Cardiology
Cited by 1

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2020.11.036

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 9

  1. Baigent, 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5 · DOI · Paper page
  2. Nicholls, 2011, Effect of two intensive statin regimens on progression of coronary disease, N Engl J Med, 365, 2078, 10.1056/NEJMoa1110874 · DOI · Paper page
  3. Banerjee, 2020, Plaque Regression and Endothelial Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Circ Cardiovasc Interv, 13, 10.1161/CIRCINTERVENTIONS.119.008933 · DOI
  4. Oyama, 2021, Effect of evolocumab on complex coronary disease requiring revascularization, J Am Coll Cardiol, 77, 259, 10.1016/j.jacc.2020.11.011 · DOI · Paper page
  5. Suh, 2010, The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation, J Am Coll Cardiol Intv, 3, 383, 10.1016/j.jcin.2009.10.033 · doi:10.1016/j.jcin.2009.10.033
  6. Mauri, 2004, Effects of stent length and lesion length on coronary restenosis, Am J Cardiol, 93, 1340, 10.1016/j.amjcard.2004.02.027 · doi:10.1016/j.amjcard.2004.02.027
  7. Patti, 2007, Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial, J Am Coll Cardiol, 49, 1272, 10.1016/j.jacc.2007.02.025 · DOI · Paper page
  8. Farkouh, 2020, Influence of LDL-cholesterol lowering on cardiovascular outcomes in patients with diabetes mellitus undergoing coronary revascularization, J Am Coll Cardiol, 76, 2197, 10.1016/j.jacc.2020.09.536 · DOI
  9. Koskinas, 2019, Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS), J Am Coll Cardiol, 74, 2452, 10.1016/j.jacc.2019.08.010 · DOI · Paper page

Cited by

See all 1

Metadata

Authors
Ohman, E. M., & Nanna, M. G.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2021-01
Volume
77
Issue
3
Pages
268-270
ISSN
0735-1097
Cited by
1
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.